Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Dakota Territory Resource Corp. stock logo
DTRC
Dakota Territory Resource
$5.00
$1.93
$8.99
N/AN/AN/A7,000 shs
Opiant Pharmaceuticals, Inc. stock logo
OPNT
Opiant Pharmaceuticals
$20.58
$7.34
$29.25
$108.83M0.8477,920 shs562,700 shs
U.S. Gold Corp. stock logo
USAU
U.S. Gold
$4.79
+4.1%
$4.03
$2.92
$5.05
$44.69M1.1958,064 shs120,998 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Dakota Territory Resource Corp. stock logo
DTRC
Dakota Territory Resource
0.00%0.00%0.00%0.00%0.00%
Opiant Pharmaceuticals, Inc. stock logo
OPNT
Opiant Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%
U.S. Gold Corp. stock logo
USAU
U.S. Gold
+8.24%+4.55%+3.84%+43.75%+11.38%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Dakota Territory Resource Corp. stock logo
DTRC
Dakota Territory Resource
N/AN/AN/AN/AN/AN/AN/AN/A
Opiant Pharmaceuticals, Inc. stock logo
OPNT
Opiant Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
U.S. Gold Corp. stock logo
USAU
U.S. Gold
2.4394 of 5 stars
3.53.00.00.03.12.50.0

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Dakota Territory Resource Corp. stock logo
DTRC
Dakota Territory Resource
N/AN/AN/AN/A
Opiant Pharmaceuticals, Inc. stock logo
OPNT
Opiant Pharmaceuticals
N/AN/AN/AN/A
U.S. Gold Corp. stock logo
USAU
U.S. Gold
3.00
Buy$14.50202.71% Upside

Current Analyst Ratings

Latest OPNT, DTRC, and USAU Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/1/2024
U.S. Gold Corp. stock logo
USAU
U.S. Gold
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$11.00
(Data available from 5/14/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Dakota Territory Resource Corp. stock logo
DTRC
Dakota Territory Resource
N/AN/AN/AN/AN/AN/A
Opiant Pharmaceuticals, Inc. stock logo
OPNT
Opiant Pharmaceuticals
$47.78M0.00N/A24.75$9.92 per share0.00
U.S. Gold Corp. stock logo
USAU
U.S. Gold
N/AN/AN/AN/A$2.24 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Dakota Territory Resource Corp. stock logo
DTRC
Dakota Territory Resource
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Opiant Pharmaceuticals, Inc. stock logo
OPNT
Opiant Pharmaceuticals
$3.01M-$6.56N/AN/AN/A-147.90%-97.03%-59.66%N/A
U.S. Gold Corp. stock logo
USAU
U.S. Gold
-$7.61M-$0.73N/AN/AN/A-40.73%-31.42%7/29/2024 (Estimated)

Latest OPNT, DTRC, and USAU Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/18/2024Q3 2024
U.S. Gold Corp. stock logo
USAU
U.S. Gold
N/A-$0.18-$0.18-$0.18N/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Dakota Territory Resource Corp. stock logo
DTRC
Dakota Territory Resource
N/AN/AN/AN/AN/A
Opiant Pharmaceuticals, Inc. stock logo
OPNT
Opiant Pharmaceuticals
N/AN/AN/AN/AN/A
U.S. Gold Corp. stock logo
USAU
U.S. Gold
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Dakota Territory Resource Corp. stock logo
DTRC
Dakota Territory Resource
N/AN/AN/A
Opiant Pharmaceuticals, Inc. stock logo
OPNT
Opiant Pharmaceuticals
0.60
5.48
5.48
U.S. Gold Corp. stock logo
USAU
U.S. Gold
N/A
10.49
10.49

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Dakota Territory Resource Corp. stock logo
DTRC
Dakota Territory Resource
N/A
Opiant Pharmaceuticals, Inc. stock logo
OPNT
Opiant Pharmaceuticals
42.39%
U.S. Gold Corp. stock logo
USAU
U.S. Gold
6.64%

Insider Ownership

CompanyInsider Ownership
Dakota Territory Resource Corp. stock logo
DTRC
Dakota Territory Resource
59.26%
Opiant Pharmaceuticals, Inc. stock logo
OPNT
Opiant Pharmaceuticals
25.15%
U.S. Gold Corp. stock logo
USAU
U.S. Gold
12.59%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Dakota Territory Resource Corp. stock logo
DTRC
Dakota Territory Resource
N/AN/AN/ANot Optionable
Opiant Pharmaceuticals, Inc. stock logo
OPNT
Opiant Pharmaceuticals
375.27 million3.87 millionNot Optionable
U.S. Gold Corp. stock logo
USAU
U.S. Gold
49.33 million8.16 millionOptionable

OPNT, DTRC, and USAU Headlines

Recent News About These Companies

Gold price today: Gold is down 0.75% from yesterday
U.S. Gold receives mine operating permit
Stocks in play: U.S. Gold Corp.

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Dakota Territory Resource logo

Dakota Territory Resource

OTCMKTS:DTRC
Dakota Territory Resource Corp., an exploration stage company, engages in the acquisition, exploration, and development of gold properties in the United States. It holds 100% interests in eight mineral properties, including the Blind Gold, City Creek, Tinton, West Corridor, Ragged Top, Poorman Anticline, Maitland, and Homestake Paleoplacer properties covering an area of approximately 19,500 acres located in the Black Hills of South Dakota. The company was formerly known as Mustang Geothermal Corp and changed its name to Dakota Territory Resource Corp. in September 2012. Dakota Territory Resource Corp. was incorporated in 2002 and is headquartered in Lead, South Dakota.
Opiant Pharmaceuticals logo

Opiant Pharmaceuticals

NASDAQ:OPNT
Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Santa Monica, CA.
U.S. Gold logo

U.S. Gold

NASDAQ:USAU
U.S. Gold Corp. engages in the exploration and development of gold and precious metals in the United States. It also explores for copper and silver deposits. The company holds 100% interests in the CK Gold project, which consists of various mining leases and other mineral rights covering approximately 1,120 acres in Laramie County, Wyoming; the Keystone project that consists of 601 unpatented lode mining claims covering approximately 20 square miles in Eureka County, Nevada; and the Challis Gold project, which consists of 77 unpatented lode mining claims covering approximately 1,710 acres in Lemhi County, Idaho. It also has earn-in agreement to acquire a 50% ownership interest in the Maggie Creek project located in Eureka County, Nevada. The company was formerly known as Dataram Corporation and changed its name to U.S. Gold Corp. in June 2017. U.S. Gold Corp. is based in Elko, Nevada.